GE HealthCare Technologies Inc. Files 8-K

Ticker: GEHC · Form: 8-K · Filed: 2025-12-15T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, financial-obligation

TL;DR

GE HealthCare just filed an 8-K for a material agreement and financial obligation. Keep an eye on this.

AI Summary

On December 12, 2025, GE HealthCare Technologies Inc. entered into a material definitive agreement. This filing also indicates the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement by the registrant. The report was filed on December 15, 2025.

Why It Matters

This 8-K filing signals a significant financial event or obligation for GE HealthCare Technologies Inc., potentially impacting its financial structure and future operations.

Risk Assessment

Risk Level: medium — Material definitive agreements and new financial obligations can introduce financial risks and operational changes that warrant closer examination.

Key Players & Entities

FAQ

What type of material definitive agreement did GE HealthCare Technologies Inc. enter into?

The filing indicates the entry into a material definitive agreement but does not specify the nature of the agreement in the provided text.

What is the nature of the direct financial obligation or off-balance sheet arrangement?

The filing states the creation of such an obligation but does not provide specific details about its terms or amount in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported is dated December 12, 2025.

What is the principal executive address of GE HealthCare Technologies Inc.?

The principal executive address is 500 W. Monroe Street, Chicago, IL 60661.

What is the SIC code for GE HealthCare Technologies Inc.?

The Standard Industrial Classification (SIC) code is 3844, related to X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS.

From the Filing

0001193125-25-319383.txt : 20251215 0001193125-25-319383.hdr.sgml : 20251215 20251215170244 ACCESSION NUMBER: 0001193125-25-319383 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20251212 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251215 DATE AS OF CHANGE: 20251215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 251572370 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 8-K 1 d75788d8k.htm 8-K 8-K false 0001932393 0001932393 2025-12-12 2025-12-12     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 12, 2025     GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter)       Delaware   001-41528   88-2515116 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   500 W. Monroe Street , Chicago , IL   60661 (Address of principal executive offices)   (Zip Code) (Registrant’s telephone number, including area code) (833) 735-1139 (Former name or former address, if changed since last report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common stock, par value $0.01 per share   GEHC   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐       Item 1.01 Entry into a Material Definitive Agreement. On December 12, 2025, GE HealthCare Technologies Inc. (the “Company”) entered into a three-year senior unsecured term loan credit facility (the “Term Loan Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein. Purs

View on Read The Filing